- Home
- NBTX vs WDI Comparison
NBTX vs WDI Comparison
Compare NBTX & WDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NBTX
- WDI
- Stock Information
- Founded
- NBTX 2003
- WDI 2021
- Country
- NBTX France
- WDI United States
- Employees
- NBTX N/A
- WDI N/A
- Industry
- NBTX Biotechnology: Pharmaceutical Preparations
- WDI Trusts Except Educational Religious and Charitable
- Sector
- NBTX Health Care
- WDI Finance
- Exchange
- NBTX Nasdaq
- WDI Nasdaq
- Market Cap
- NBTX 868.8M
- WDI 788.9M
- IPO Year
- NBTX 2020
- WDI N/A
- Fundamental
- Price
- NBTX $21.04
- WDI $14.89
- Analyst Decision
- NBTX Strong Buy
- WDI
- Analyst Count
- NBTX 1
- WDI 0
- Target Price
- NBTX $8.00
- WDI N/A
- AVG Volume (30 Days)
- NBTX 112.7K
- WDI 192.6K
- Earning Date
- NBTX 09-30-2025
- WDI 01-01-0001
- Dividend Yield
- NBTX N/A
- WDI 11.80%
- EPS Growth
- NBTX N/A
- WDI N/A
- EPS
- NBTX N/A
- WDI 1.12
- Revenue
- NBTX $11,930,711.00
- WDI N/A
- Revenue This Year
- NBTX N/A
- WDI N/A
- Revenue Next Year
- NBTX $74.67
- WDI N/A
- P/E Ratio
- NBTX N/A
- WDI $12.82
- Revenue Growth
- NBTX N/A
- WDI N/A
- 52 Week Low
- NBTX $2.76
- WDI $12.16
- 52 Week High
- NBTX $22.51
- WDI $14.69
- Technical
- Relative Strength Index (RSI)
- NBTX 71.69
- WDI 45.99
- Support Level
- NBTX $19.11
- WDI $14.60
- Resistance Level
- NBTX $22.64
- WDI $14.99
- Average True Range (ATR)
- NBTX 1.64
- WDI 0.14
- MACD
- NBTX 0.63
- WDI -0.01
- Stochastic Oscillator
- NBTX 83.03
- WDI 42.65
About NBTX Nanobiotix S.A.
Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.
About WDI Western Asset Diversified Income Fund of Beneficial Interest
Western Asset Diversified Income Fund is a newly-organized, diversified, closed-end management investment company. The fund's primary investment objective is to seek high current income.